Fmr LLC Kintara Therapeutics, Inc. Transaction History

Fmr LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.5 $19 - $70	-140 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.31 - $0.55 $43 - $77	140 New	140 $0
Q4 2021 Feb 14, 2022	SELL	$0.51 - $1.04 $7,650 - $15,600	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.82 - $2.3 $12,300 - $34,500	15,000 New	15,000 $12,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $13.7M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.